EUVIMEDEUVIMED entdecken
Crossref

Increased indolamine 2,3-dioxygenase activity in people with type 2 diabetes and comorbid depression

Proteesh Rana, Mina Chandra, Kalpana Chandra, Shrishti Dahuja, Bijo Varughese, Vandana Roy, Seema Kapoor, Murali Rao

The National Medical Journal of India · 2026

DOI: 10.25259/nmji_1101_2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The National Medical Journal of India, 2026. Verfasst von Proteesh Rana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University College of Medical Sciences, Delhi, India. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Indoleamine-Pyrrole 2,3,-Dioxygenase, Depression. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depression is a major psychiatric comorbid condition of type 2 diabetes mellitus (T2DM). Serotonin, the major neurotransmitter implicated in depression, is a tryptophan derivative. Tryptophan is chiefly metabolised through the kynurenine pathway with indolamine-2,3-dioxygenase (IDO) as the rate-limiting enzyme. Hence, serum tryptophan and kynurenine concentrations and their ratio (K/T ratio) as a measure of IDO activity are possible biomarkers of depression in T2DM.

Methods

Severity of depression in adults with T2DM attending a primary care facility in Delhi was rated using the Hamilton Depression Rating Scale (HAM-D 17 items). Baseline serum tryptophan and kynurenine concentrations, along with their ratio, were estimated. A follow-up HAM-D rating was done after 16 weeks of standard therapy and the quantum HAM-D score improvement was correlated with the K/T ratio.

Results

Of 106 people with T2DM screened for depression, 52 had syndromal depression and were recruited for the study. There was no significant association between age, sex, marital status, religion, serum tryptophan, and kynurenine levels with respect to the severity of depression, but the mean K/T ratio was significantly higher among those with severe depression (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Indoleamine-Pyrrole 2,3,-DioxygenaseDepressionHumansKynurenineTryptophanMaleFemaleMiddle AgedBiomarkersIndiaComorbidityAdultSeverity of Illness Index

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseKynurenineTryptophanBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacology, University College of Medical Sciences, Delhi, India.
  • Department of Psychiatry, Centre of Excellence in Mental Health, Atal Bihari Vajpayee Institute of Medical Sciences (Formerly PGIMER) and Dr Ram Manohar Lohia Hospital, New Delhi, India.
  • Delhi Jal Board, Government of National Capital Territory of Delhi, Delhi, India.
  • Department of Paediatrics, Maulana Azad Medical College, New Delhi, India.
  • Department of Pharmacology, Maulana Azad Medical College, New Delhi, India.
  • Department of Psychiatry, Loyola University, Chicago, United States.

Zitieren

APA

Rana, P., Chandra, M., Chandra, K., Dahuja, S., Varughese, B., Roy, V., Kapoor, S., & Rao, M. (2026). Increased indolamine 2,3-dioxygenase activity in people with type 2 diabetes and comorbid depression. The National Medical Journal of India. https://doi.org/10.25259/nmji_1101_2023

Vancouver

Rana P, Chandra M, Chandra K, Dahuja S, Varughese B, Roy V, et al. Increased indolamine 2,3-dioxygenase activity in people with type 2 diabetes and comorbid depression. The National Medical Journal of India. 2026. doi:10.25259/nmji_1101_2023

BibTeX
@article{Rana2026,
  author = {Rana, Proteesh and Chandra, Mina and Chandra, Kalpana and Dahuja, Shrishti and Varughese, Bijo and Roy, Vandana and Kapoor, Seema and Rao, Murali},
  title = {Increased indolamine 2,3-dioxygenase activity in people with type 2 diabetes and comorbid depression},
  journal = {The National Medical Journal of India},
  year = {2026},
  doi = {10.25259/nmji_1101_2023}
}
Kostenlos starten →